Summary
64 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $29.5M against $11.8M.
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 12 USD is left as net profit.
- Revenue grew by 12% a year over the last 3 years.
What to watch
- It pays out more in dividends than it earns: 109% of profit.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 20.0 USD for 1 USD of yearly profit. Over the last five years it was 28.1 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.3% a year over 5 years. Over the last 3 years it grew by 12% a year.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 59 USD
- Research and development 5.2 USD
- Sales and administration 21 USD
- Taxes and other 2.9 USD
- Net profit 12 USD
Net profit, industry median (Drug Manufacturers - Specialty & Generic) 10 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 5.43%
- Paid out of profit
- 109%
You receive $0.42 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 5
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $15 is 94% above today's price. 83% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Distribution Member 100%
By region
- Other Foreign Countries Member 41%
- Latin America 34%
- CANADA 15%
- Asia 9.4%
- Other Countries Member 0.1%
Distribution Member brings in 100% of revenue.
Segments in detail